Lisa A Kottschade

Lisa A Kottschade

UNVERIFIED PROFILE

Are you Lisa A Kottschade?   Register this Author

Register author
Lisa A Kottschade

Lisa A Kottschade

Publications by authors named "Lisa A Kottschade"

Are you Lisa A Kottschade?   Register this Author

43Publications

912Reads

49Profile Views

The Future of Immunotherapy in the Treatment of Cancer.

Semin Oncol Nurs 2019 Aug 30:150934. Epub 2019 Aug 30.

Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soncn.2019.08.013DOI Listing
August 2019

Neoadjuvant systemic therapy for regionally advanced melanoma.

J Surg Oncol 2018 May 11;117(6):1164-1169. Epub 2017 Dec 11.

Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24939DOI Listing
May 2018

Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience.

Arthritis Rheumatol 2018 03 6;70(3):356-360. Epub 2018 Feb 6.

Mayo Clinic College of Medicine, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40397DOI Listing
March 2018

Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors.

Curr Oncol Rep 2018 03 6;20(3):24. Epub 2018 Mar 6.

Department of Oncology-Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0671-4DOI Listing
March 2018

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.

Cancer Med 2017 Oct 6;6(10):2203-2212. Epub 2017 Sep 6.

Department of Oncology, Division of Medical Oncology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633552PMC
October 2017

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients.

Melanoma Res 2017 02;27(1):32-42

aDepartment of Health Science Research, Division of Biomedical Statistics and Informatics bDepartment of Medical Oncology cDepartment of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000290DOI Listing
February 2017

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.

Melanoma Res 2016 12;26(6):609-615

Departments of aInternal Medicine bPharmacy Services cOncology dCancer Center Statistics, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000299DOI Listing
December 2016

The use of pembrolizumab for the treatment of metastatic uveal melanoma.

Melanoma Res 2016 06;26(3):300-3

Departments of aOncology bHematology cImmunology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000242DOI Listing
June 2016

Ipilimumab-induced colitis in patients with metastatic melanoma.

Melanoma Res 2015 Aug;25(4):321-7

aDivision of Gastroenterology and Hepatology bDivision of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000165DOI Listing
August 2015

The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.

Am J Clin Oncol 2015 Jun;38(3):252-8

Departments of *Medical Oncology †Surgery ‡Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31829b5605DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864631PMC
June 2015

Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases.

Melanoma Res 2015 Feb;25(1):75-9

aMasonic Cancer Center, University of Minnesota, Minneapolis bDepartment of Medical Oncology, Mayo Clinic cMidwest Melanoma Partnership, Rochester, Minnesota dDivision of Hematology/Oncology, University of Illinois Cancer Center, Chicago, Illinois, USA eIstituto Oncologico, Veneto, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000133DOI Listing
February 2015

Rare presentations of primary melanoma and special populations: a systematic review.

Am J Clin Oncol 2014 Dec;37(6):635-41

Departments of *Oncology †Surgery ‡Laboratory Medicine and Pathology §Ophthalmology #Dermatology ‡‡Radiation Oncology **Pediatrics §§Radiology ∥∥Hematology ¶¶Immunology ††Medical Genetics, Mayo Clinic, Rochester, MN ∥Department of Pediatric Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada ¶The Queen's Medical Center/Queen's Cancer Center, University of Hawaii/John A. Burns School of Medicine, Honolulu, HI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3182868e82DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349521PMC
December 2014

Nursing's presence in the changing cooperative group setting.

Semin Oncol Nurs 2014 Feb 17;30(1):32-7. Epub 2013 Dec 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soncn.2013.12.006DOI Listing
February 2014

Vemurafenib for melanoma metastases to the brain.

N Engl J Med 2011 Dec;365(25):2439-41

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1111672DOI Listing
December 2011

In-transit melanoma: an individualized approach.

Oncology (Williston Park) 2011 Dec;25(14):1340-8

Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
December 2011

Pilot evaluation of flaxseed for the management of hot flashes.

J Soc Integr Oncol 2007 ;5(3):106-12

Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
December 2007

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.

Cancer 2006 Jan;106(2):375-82

Department of Medical Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21611DOI Listing
January 2006